SEC 13F Intelligence

Ameriprise Financial Inc / ABT

Ameriprise Financial Inc’s Abbott Laboratories Position

Does Ameriprise Financial Inc own Abbott Laboratories (ABT)? Yes — 14.12M shares worth $1.4B (+0.33% of its 13F portfolio) as of Q1 2026, up from 13.18M shares the prior filed quarter.

Position Value
$1.4B
Q1 2026
Shares
14.12M
% of Portfolio
+0.33%
Quarters Held
25
currently held

Position History ABT

Reported value by quarter
Q1 ’20: $952MQ1 ’20Q2 ’20: $1.1BQ3 ’20: $1.5BQ4 ’20: $1.5BQ1 ’21: $1.7BQ1 ’21Q2 ’21: $1.6BQ3 ’21: $1.9BQ4 ’21: $2.5BQ1 ’22: $1.7BQ1 ’22Q2 ’22: $1.6BQ3 ’22: $1.4BQ4 ’22: $1.7BQ1 ’23: $1.2BQ1 ’23Q2 ’23: $1.3BQ3 ’23: $1.0BQ4 ’23: $1.1BQ1 ’24: $1.2BQ1 ’24Q2 ’24: $1.1BQ3 ’24: $1.4BQ4 ’24: $1.5BQ1 ’25: $1.6BQ1 ’25Q2 ’25: $1.8BQ3 ’25: $1.8BQ4 ’25: $1.6BQ1 ’26: $1.4BQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202614.12M$1.4B+0.33%
Q4 202513.18M$1.6B+0.37%
Q3 202513.50M$1.8B+0.41%
Q2 202513.00M$1.8B+0.43%
Q1 202512.06M$1.6B+0.43%
Q4 202412.87M$1.5B+0.37%
Q3 202412.08M$1.4B+0.35%
Q2 202410.68M$1.1B+0.30%
Q1 202410.17M$1.2B+0.32%
Q4 20239.65M$1.1B+0.32%
Q3 202310.74M$1.0B+0.34%
Q2 202311.95M$1.3B+0.41%
Q1 202311.76M$1.2B+0.39%
Q4 202215.13M$1.7B+0.57%
Q3 202214.91M$1.4B+0.53%
Q2 202215.06M$1.6B+0.57%
Q1 202214.84M$1.7B+0.51%
Q4 202117.59M$2.5B+0.68%
Q3 202116.04M$1.9B+0.61%
Q2 202114.20M$1.6B+0.51%
Q1 202113.77M$1.7B+0.55%
Q4 202014.06M$1.5B+0.55%
Q3 202013.37M$1.5B+0.59%
Q2 202011.70M$1.1B+0.46%
Q1 202012.03M$952M+0.50%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ameriprise Financial Inc’s full portfolio or all institutional holders of ABT.